Combination of Proton Irradiation and Targeted Radionuclide Therapy with 177Lu-PSMA-617 in a Tumor Mouse Model of Prostate Cancer

被引：0
|
作者：
Mueller, C. [1 ]
Perrin, R. [1 ]
Umbricht, C. [1 ]
van der Meulen, N. [1 ]
Safai, S. [1 ]
Weber, D. [1 ]
Lomax, A. [1 ]
Schibli, R. [1 ]
机构：
[1] Paul Scherrer Inst, Villigen, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-160
引用
收藏
页码：S180 / S181
页数：2
相关论文
共 50 条
  • [21] Activity of 177Lu-PSMA-617 in Patients With Advanced Prostate Cancer and Brain Metastases
    Rashid, Narmeen S.
    Rami, Avina
    Lang, Min
    Stoltenberg, Hailey
    Wolanski, Andrew
    Ritzer, Jolivette
    Jacene, Heather
    Ravi, Praful
    CLINICAL GENITOURINARY CANCER, 2025, 23 (02)
  • [22] Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer
    Mader, Nicolai
    Schoeler, Christina
    Pezeshkpour, Niloufar
    Klimek, Konrad
    Groener, Daniel
    Happel, Christian
    Tselis, Nikolaos
    Mandel, Philipp
    Gruenwald, Frank
    Sabet, Amir
    CANCERS, 2023, 15 (18)
  • [23] Radionuclide therapy with 177Lu PSMA for prostate cancer
    da Rocha, Euclides Timoteo
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1527 - 1527
  • [24] Myelotoxicity after Treatment with 177Lu-PSMA-617 in Patients with Metastatic Prostate Cancer
    Groener, D.
    Baumgarten, J.
    Davis, K.
    Happel, C.
    Mader, N.
    Ngoc, C. Nguyen
    Wichert, J.
    Mandel, P.
    Tselis, N.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S694 - S695
  • [25] Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"
    Radtke, Jan Philipp
    Albers, Peter
    Giesel, Frederik Lars
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [26] The additive value of fractionated 177Lu-PSMA-617 administration in treating prostate cancer
    Zheng, Xiaobei
    Cui, Bin
    Hou, Wenli
    Zhao, Zhongqi
    He, Shuhua
    Li, Xiao
    Xue, Shuai
    Luo, Xiu
    Ma, Li
    Zhang, Lan
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2025, 334 (01) : 99 - 104
  • [27] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Kratochwil, Clemens
    Giesel, Frederik L.
    Stefanova, Melsa
    Benesova, Martina
    Bronzel, Marcus
    Afshar-Oromieh, Ali
    Mier, Walter
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 1170 - 1176
  • [28] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Mair, Christian
    Warwitz, Boris
    Fink, Katharina
    Scarpa, Lorenza
    Nilica, Bernhard
    Maffey-Steffan, Johanna
    Buxbaum, Sabine
    Virgolini, Irene J.
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (07) : 499 - 502
  • [29] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Christian Mair
    Boris Warwitz
    Katharina Fink
    Lorenza Scarpa
    Bernhard Nilica
    Johanna Maffey-Steffan
    Sabine Buxbaum
    Irene J. Virgolini
    Annals of Nuclear Medicine, 2018, 32 : 499 - 502
  • [30] Single-Time-Point Dosimetry of 177Lu-PSMA-617 Radionuclide Therapy with SPECT/CT
    Burkerr, Brian J.
    RADIOLOGY-IMAGING CANCER, 2023, 5 (02):
12345